Psychiatry Medical News about Depressive Disorder, Major

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder
Australian and New Zealand Journal of Psychiatry, 10/05/09

Nierenberg AA et al. – To the best of the authors' knowledge this is the first study to combine an antidepressant and second–generation antipsychotic at the beginning of a treatment trial for chronic or recurrent non–treatment resistant MDD. VEN–XR and ARI combination appears to warrant further study in controlled trials.

<< Previous
Safety Nets Get Stimulus I.T. Funds

Next >>
The Catatonia Conundrum: Evidence of Psychomotor Phenomena as a...